Literature DB >> 19196555

The patient presenting with isolated hyperbilirubinemia.

L Fabris1, M Cadamuro, L Okolicsanyi.   

Abstract

Hyperbilirubinemia is a common laboratory finding in clinical practice, being found in several haematological and liver diseases as well as in familial conditions (5-10% in Western countries). Although most of the familial forms of hyperbilirubinemia are classically viewed as benign conditions, they have gained an increased interest in the last few years since recent data have indicated that subjects with an impaired bilirubin metabolism may have an increased susceptibility to drug toxicity. The authors briefly review the main steps of bilirubin metabolism, with a special emphasis on the emerging concepts on the molecular mechanisms of regulation by nuclear receptors (NRs) and genetic factors. Then the different forms of isolated hyperbilirubinemia occurring in both adults and paediatrics are systematically analysed, and a new categorisation is also proposed in light of the recent advances in bilirubin research. Finally, a diagnostic algorithm is discussed, along with a correct approach to its management, in order to avoid unnecessary medical investigations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19196555     DOI: 10.1016/j.dld.2008.11.006

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  7 in total

1.  Chronic psychological stress and high-fat high-fructose diet disrupt metabolic and inflammatory gene networks in the brain, liver, and gut and promote behavioral deficits in mice.

Authors:  Maria Elizabeth de Sousa Rodrigues; Mandakh Bekhbat; Madelyn C Houser; Jianjun Chang; Douglas I Walker; Dean P Jones; Claudia M P Oller do Nascimento; Christopher J Barnum; Malú G Tansey
Journal:  Brain Behav Immun       Date:  2016-09-02       Impact factor: 7.217

2.  Allogeneic hematopoietic stem cell transplantation for acute leukemia with Gilbert's syndrome.

Authors:  Guo-Pan Yu; Qian-Li Jiang; Zhi-Ping Fan; Jie Zhao; Qi Wei; Jing Sun; Fan-Yi Meng; Qi-Fa Liu
Journal:  J Hematol Oncol       Date:  2011-03-09       Impact factor: 17.388

3.  Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability.

Authors:  Erika Assarsson; Martin Lundberg; Göran Holmquist; Johan Björkesten; Stine Bucht Thorsen; Daniel Ekman; Anna Eriksson; Emma Rennel Dickens; Sandra Ohlsson; Gabriella Edfeldt; Ann-Catrin Andersson; Patrik Lindstedt; Jan Stenvang; Mats Gullberg; Simon Fredriksson
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

4.  UGT1A1 genotypes and unconjugated hyperbilirubinemia phenotypes in post-neonatal Chinese children: A retrospective analysis and quantitative correlation.

Authors:  Kuerbanjiang Abuduxikuer; Ling-Juan Fang; Li-Ting Li; Jing-Yu Gong; Jian-She Wang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

5.  Update on a previously reported missense mutation: The c.1160 C>A mutation in the UGT1A1 gene result in Crigler-Najjar syndrome type 1.

Authors:  Mohammad Javad Ghorbani; Seyed Mohsen Dehghani
Journal:  Mol Genet Genomic Med       Date:  2021-09-21       Impact factor: 2.183

6.  Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease.

Authors:  Byoung Kuk Jang
Journal:  Clin Mol Hepatol       Date:  2012-12-21

7.  Case-control study of the efficacy of retrogastric Roux-en-Y choledochojejunostomy.

Authors:  Xin-Wei Yang; Jun-Yi Chen; Wen-Liang Yan; Jing Du; Zhi-Jian Wen; Xing-Zhou Yan; Ping-Hua Yang; Jue Yang; Bao-Hua Zhang
Journal:  Oncotarget       Date:  2017-03-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.